Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANDREW HARARAH

Allopathic & Osteopathic Physicians Family Medicine

NPI
1104920255
CMS profile
232219
Location
AMITYVILLE, NY

General Payments · PY2018–2024

$2,158.51

  • Reported across 131 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$245.84

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $245.84 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Corcept Therapeutics $63.34 3
Acerta Pharma LLC $47.28 2
SHIELD THERAPEUTICS INC $40.36 2
Renalytix AI, Inc. $33.71 2
Exact Sciences Corporation $32.71 2
Abbott Laboratories $14.35 1
Novo Nordisk AS $14.09 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $677.66 41
PY2019 $830.90 56
PY2020 $128.81 8
PY2021 $22.21 1
PY2022 $50.97 3
PY2023 $202.12 9
PY2024 $245.84 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $14.35 08/05/2024 Food and Beverage Undisputed 01/23/2026 1124849176 CMS
AstraZeneca Pharmaceuticals LP $17.20 01/16/2024 Food and Beverage Undisputed 01/23/2026 1104680119 CMS
AstraZeneca Pharmaceuticals LP $30.08 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105681813 CMS
Corcept Therapeutics $22.37 06/18/2024 Food and Beverage Undisputed 01/23/2026 1117730228 CMS
Corcept Therapeutics $25.80 08/06/2024 Food and Beverage Undisputed 01/23/2026 1117730284 CMS
Corcept Therapeutics $15.17 11/21/2024 Food and Beverage Undisputed 01/23/2026 1117730326 CMS
Exact Sciences Corporation $19.34 03/28/2024 Food and Beverage Undisputed 01/23/2026 1114692626 CMS
Exact Sciences Corporation $13.37 04/19/2024 Food and Beverage Undisputed 01/23/2026 1114692631 CMS
Novo Nordisk Inc $14.09 05/18/2024 Food and Beverage Undisputed 01/23/2026 1097554306 CMS
Renalytix AI, Inc. $18.13 08/30/2024 Food and Beverage Undisputed 01/23/2026 1116759054 CMS
Renalytix AI, Inc. $15.58 10/22/2024 Food and Beverage Undisputed 01/23/2026 1116759056 CMS
SHIELD THERAPEUTICS INC $15.35 01/30/2024 Food and Beverage Undisputed 01/23/2026 1150118501 CMS
SHIELD THERAPEUTICS INC $25.01 03/26/2024 Food and Beverage Undisputed 01/23/2026 1150125269 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.